MRI Compatible Patient Monitoring Systems Market Outlook (2022 to 2032)

The global MRI compatible patient monitoring systems market holds a forecasted share of US$ 3,851.4 million in 2022 and is likely to surpass US$ 5,958.6 million by 2032, moving ahead with a CAGR of 4% during the forecast period.

Magnetic Resonance Imaging (MRI) is a valuable diagnostic tool for identifying diseases related to spine lesions, tumors, and strokes affecting the blood vessels and the brain. The prevalence of these diseases is driving the growth of the MRI compatible patient monitoring systems market.

Report Attribute Details
MRI Compatible Patient Monitoring Systems Market Value (2022) US$ 3,851.4 million
MRI Compatible Patient Monitoring Systems Market Anticipated Forecast Value (2032) US$ 5,958.6 million
MRI Compatible Patient Monitoring Systems Market Projected Growth Rate (2022 to 2032) 4%

In 2020, the International Agency for Research on Cancer reported 19,292,789 new cancer cases worldwide. MRI machines are expected to be widely adopted due to the growing demand for quick and effective diagnostic procedures. Various countries are installing these MRI machines. According to the OECD, 34.54 MRI units were installed in the USA in 2020. Artificial intelligence may also have a positive impact on the market in the future.

MRI compatible patient monitoring systems are technologically modified and equipped with safety features, such as alarms or other operator alerts that are meant to trigger in the event of a problem, thus shaping key trends and opportunities in the market for MRI compatible patient monitoring systems.

There has been a tremendous amount of advancement in MRI technology over recent years, especially in the software field. It has also been driven by advancements in diagnostic techniques such as open MRI, visualization software, and superconducting magnets. Furthermore, the development of cardiac pacemaker-compatible MRI systems is expected to propel market growth in the cardiology segment.

Further, various paramagnetic contrast agents, such as gadolinium-DTPA, can be injected intravenously to provide sharp, precise, and accurate images within a short period. As a result of these technological advancements in MRI, market growth is expected to accelerate during the forecast period.

MRI manufacturers have continued to adopt newer technology and develop artificial intelligence (AI)-based solutions to increase the market growth. Radiologists used this to understand chronic diseases and residual symptoms more effectively and efficiently. MRI is expected to play a key role in patient monitoring as clinicians seek to find out what is causing long-term chronic disease symptoms

Several recent advancements, such as diffusion and diffusion tensor imaging with tractography, neuroimaging such as MR spectroscopy, perfusion imaging, and functional imaging utilizing the bold technique, are expected to boost market growth during the forecast period. It is also expected that the market will grow as intraoperative MRI grows in popularity and is applied in several applications, including neurosurgery.

There are several advantages associated with MRI systems, but the costs associated with purchasing and installing such machines are quite high, which in turn affects the growth of the market, particularly in developing regions. Low- to medium-strength MRI machines cost more than one million dollars on average. Furthermore, helium gas is depleting at an alarming rate, resulting in increased wait time and a reduction in productivity.

The growth of the market is also negatively impacted by the delayed approval of products and frequent recalls of products primarily because of stringent regulatory frameworks.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key MRI Compatible Patient Monitoring Systems Market Dynamics?

Drivers:

  • Increase in Prevalence of Chronic Disorders: As chronic diseases become more prevalent, the global market for MRI compatible patient monitoring systems is expected to grow. For instance, specifically, the American Cancer Society estimates that the USA will suffer from 1.9 million new cancer cases and 609,360 cancer deaths in 2022.
  • Launch of New Products: Over the forecast period, key market players are expected to launch more products to drive growth in the global MRI compatible patient monitoring systems market. For example, Cannon Medical, a medical equipment company, launched a new MRI system in July 2022 at the ECR (European Congress of Radiology) 2022 conference. MRI procedures are shortened with the new system because it incorporates innovative workflow solutions, image enhancement, and faster scan technologies.
  • Growing access to compatible medical services will likely fuel the demand for MRI compatible patient monitoring systems as large volumes of patients undergo MRI procedures.

Restraints:

It is anticipated that mixed results with MRI screening may hinder the growth of the global MRI compatible patient monitoring systems market. For instance, in November 2019, researchers at Utrecht University Medical Center, The Netherlands, published a study finding that the rate of interval cancers was reduced by half in patients with dense breast tissue when mammography was complemented with magnetic resonance imaging (MRI). However, there was a significant rate of recall for additional imaging.

Some factors will limit the growth of the MRI compatible patient monitoring system market in the future. These factors include the risk associated with MRI scans, the strict regulatory requirements for approving devices, and the high cost of devices. An MRI examination takes a considerable amount of time, and critically ill patients and children are sometimes sedated during the procedure. Medical conditions like respiratory depression and hypoxemia can sometimes result from these scans. According to the Safety Committee of the Society for Magnetic Resonance Imaging, MRI procedures should be physiologically monitored and performed only by a qualified professional.

Opportunities:

There may be ample growth opportunities for players in the MRI compatible patient monitoring system market in several unexplored markets in emerging economies. By monitoring the patient's vital signs, these systems help to avoid any emergencies during the scan. Among the vital signs that can be monitored with these systems are electrocardiography, pulse oximetry, and invasive blood pressure (IBP).

Further, these systems can be used to monitor pediatric patients, patients who are mentally ill, and critically ill patients, as well as patients with compromised physiologic functions. In this way, the players may be able to expand their product portfolios as the number of applications for these systems grows.

Regional Analysis

How is North America Dominating the MRI Compatible Patient Monitoring Systems Market?

With a market share of 35.2% in 2022, North America is expected to dominate the MRI compatible patient monitoring systems market. As a result of an increasing geriatric population, lifestyle-associated diseases, and the adoption of technologically advanced devices, North America may dominate the global MRI compatible patient monitoring system market in the years to come. As medical infrastructure and reimbursement facilities develop along with technological advancements, the North American MRI compatible patient monitoring systems market is expected to register significant growth over the forecast period.

The North American MRI compatible patient monitoring system market size is expected to grow due to high healthcare spending and rising chronic disease prevalence.

The European MRI Compatible Patient Monitoring Systems Market is a Promising One.

Europe is expected to contribute modestly to the market, as well as a healthy growth rate, with MRI compatible patient monitoring systems occupying 31.9% of the market in 2022.

With an increase in elderly people and growing awareness about MRI compatible patient monitoring systems, the European MRI compatible patient monitoring systems market is expected to grow. In fact, 47% of the four million deaths there each year are caused by cardiovascular diseases, according to the European Society of Cardiology, a non-profit medical organization.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is the Start-up Ecosystem in the MRI Compatible Patient Monitoring Systems Market?

In developing economies, favorable government policies for start-up companies like medical device manufacturers and new manufacturing facilities support capacity expansion by leading manufacturers.

The Butterfly iQ, created by Butterfly Network, is a portable, handheld ultrasound imaging device with a built-in battery and wireless charging that can perform scans for more than two hours. Butterfly Network was founded in 2011.

Additionally, it enables the organization, searching, and access of cloud-based studies via mobile or web. Several prominent investors have contributed to the raising of US$ 350 million raised by this start-up, triggering new trends in the market for MRI-compatible patient monitoring systems.

MRI Compatible Patient Monitoring Systems Market: Competitive Landscape

MRI Compatible Patient Monitoring Systems Market: Key Contracts/ Agreements/ Acquisitions/ Recent Developments

To increase the adoption and usage of MRI machines in the field of medical imaging, key players are developing machines with high field strength. Aside from expansions of their regional and service portfolios, these players are also undertaking mergers and acquisitions.

  • In June 2021, Philips announced a strategic partnership with Akumin Inc., a leading outpatient diagnostic imaging provider in the United States, to utilize Philips' new Radiology Operations Command Center across Akumin's outpatient imaging centers and to establish clinical standards for Akumin's MR and CT imaging technologies.
  • As part of the ECR (European Congress of Radiology) 2021 meeting, Hitachi, Ltd., a Japanese multinational conglomerate corporation, announced the launch of two upgraded open MRIs, the APERTO Lucent Plus 0.4T permanent open MRI and the AIRIS Vento Plus 0.3T permanent open MRI. With Synergy Drive workflow solutions, the latest MRI systems optimize workflow and reduce scan times. From the beginning of the MRI scanning procedure to the post-processing and sharing of MRI images, the Synergy Drive workflow solution helps overcome barriers to MRI scanning.
  • Philips announced the launch of an AI-enabled MR imaging portfolio in November 2021, aimed at improving the efficiency and sustainability of radiology operations by speeding up MR exams, streamlining workflows, increasing diagnostic quality, and ensuring radiology operations are efficient and sustainable.
  • FUJIFILM Healthcare released its Velocity MRI System in December 2021, which features a high-field open gantry. This advanced and high-field MRI system streamlines operations and improves the patient experience.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Who are the Key Players in the MRI Compatible Patient Monitoring Systems Market?

  • Arcomed AG
  • PULSION Medical Systems SE
  • LiDCO Group PLC
  • CAS Medical Systems
  • Deltex Medical Group PLC
  • Philips Medical Systems
  • GE Healthcare
  • Draeger Medical, Inc.
  • Schwarzer Cardiotek GmbH
  • Tensys Medical, Inc.

Report Scope

Report Attribute Details
Growth Rate CAGR of 4% from 2022 to 2032
Base Year for Estimation 2022
Historical Data 2016 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in US$ Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Product Type
  • Modality Type
  • Application
  • End Use
  • Region
Regions Covered
  • North America
  • Latin America
  • The Asia Pacific
  • Middle East and Africa(MEA)
  • Europe
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • GCC Countries
  • South Africa
Key Companies Profiled
  • Arcomed AG
  • PULSION Medical Systems SE
  • LiDCO Group PLC
  • CAS Medical Systems
  • Deltex Medical Group PLC
  • Philips Medical Systems
  • GE Healthcare
  • Draeger Medical, Inc.
  • Schwarzer Cardiotek GmbH
  • Tensys Medical, Inc.
Customization Available Upon Request

Key Segments Profiled in the MRI Compatible Patient Monitoring Systems Market Survey

By Product Type:

  • Magnetic Devices
  • Non-magnetic Devices

By Modality Type:

  • Portable
  • Non-portable

By Application:

  • Blood Glucose Monitoring
  • EEG and ECG Monitoring
  • Capnography Monitoring
  • Spirometer Monitoring
  • Sleep Apnea Monitoring
  • Pulse Oximeter Monitoring
  • Foetal Doppler Monitoring
  • Multi-parameter Monitoring
  • Weight Monitoring
  • Temperature Monitoring
  • Others

By End Use:

  • Hospitals
  • Ambulatory Surgical Centres
  • Diagnostics Centres
  • Emergency Medical Services
  • Others

By Region:

  • North America
  • Latin America
  • The Asia Pacific
  • Middle East and Africa(MEA)
  • Europe

Frequently Asked Questions

What is the Growth Potential of the MRI Compatible Patient Monitoring Systems Market?

The MRI compatible patient monitoring systems market's growth potential can be valued at US$ 5958.6 Million by 2032.

What is the Market Size of the Global MRI Compatible Patient Monitoring Systems Market?

The market size of the global MRI Compatible Patient Monitoring Systems Market is projected to grow by US$ 3851.4 Million in 2022.

How is the MRI Compatible Patient Monitoring Systems Market Growing?

The MRI compatible patient monitoring systems market is expected to grow at a CAGR of 4% from 2022 to 2032.

Which Region is Expected to Hold the Highest Share in the Global MRI Compatible Patient Monitoring Systems Market?

North America is expected to hold the highest share in the global MRI compatible patient monitoring systems market.

Table of Content
1. Executive Summary | MRI Compatible Patient Monitoring Systems Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032

        5.3.1. Magnetic Devices

        5.3.2. Non-magnetic Devices

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Modality Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Modality Type, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality Type, 2022 to 2032

        6.3.1. Portable

        6.3.2. Non-portable

    6.4. Y-o-Y Growth Trend Analysis By Modality Type, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By Modality Type, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032

        7.3.1. Blood Glucose Monitoring

        7.3.2. EEG and ECG Monitoring

        7.3.3. Capnography Monitoring

        7.3.4. Spirometer Monitoring

        7.3.5. Sleep Apnea Monitoring

        7.3.6. Pulse Oximeter Monitoring

        7.3.7. Fetal Doppler Monitoring

        7.3.8. Multi-parameter Monitoring

        7.3.9. Weight Monitoring

        7.3.10. Temperature Monitoring

        7.3.11. Other Applications

    7.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021

    7.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Diagnostics Centers

        8.3.4. Emergency Medical Services

        8.3.5. Others

    8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021

    8.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032

9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa(MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Product Type

        10.2.3. By Modality Type

        10.2.4. By Application

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Modality Type

        10.3.4. By Application

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product Type

        11.2.3. By Modality Type

        11.2.4. By Application

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Modality Type

        11.3.4. By Application

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United Kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Product Type

        12.2.3. By Modality Type

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Modality Type

        12.3.4. By Application

        12.3.5. By End User

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

            13.2.1.4. India

            13.2.1.5. Malaysia

            13.2.1.6. Singapore

            13.2.1.7. Australia

            13.2.1.8. New Zealand

            13.2.1.9. Rest of Asia Pacific

        13.2.2. By Product Type

        13.2.3. By Modality Type

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Modality Type

        13.3.4. By Application

        13.3.5. By End User

    13.4. Key Takeaways

14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of Middle East and Africa(MEA)

        14.2.2. By Product Type

        14.2.3. By Modality Type

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Modality Type

        14.3.4. By Application

        14.3.5. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Product Type

            15.1.2.2. By Modality Type

            15.1.2.3. By Application

            15.1.2.4. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Product Type

            15.2.2.2. By Modality Type

            15.2.2.3. By Application

            15.2.2.4. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Product Type

            15.3.2.2. By Modality Type

            15.3.2.3. By Application

            15.3.2.4. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Product Type

            15.4.2.2. By Modality Type

            15.4.2.3. By Application

            15.4.2.4. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Product Type

            15.5.2.2. By Modality Type

            15.5.2.3. By Application

            15.5.2.4. By End User

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Product Type

            15.6.2.2. By Modality Type

            15.6.2.3. By Application

            15.6.2.4. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Product Type

            15.7.2.2. By Modality Type

            15.7.2.3. By Application

            15.7.2.4. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Product Type

            15.8.2.2. By Modality Type

            15.8.2.3. By Application

            15.8.2.4. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Product Type

            15.9.2.2. By Modality Type

            15.9.2.3. By Application

            15.9.2.4. By End User

    15.10. China

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Product Type

            15.10.2.2. By Modality Type

            15.10.2.3. By Application

            15.10.2.4. By End User

    15.11. Japan

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Product Type

            15.11.2.2. By Modality Type

            15.11.2.3. By Application

            15.11.2.4. By End User

    15.12. South Korea

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Product Type

            15.12.2.2. By Modality Type

            15.12.2.3. By Application

            15.12.2.4. By End User

    15.13. Malaysia

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Product Type

            15.13.2.2. By Modality Type

            15.13.2.3. By Application

            15.13.2.4. By End User

    15.14. Singapore

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Product Type

            15.14.2.2. By Modality Type

            15.14.2.3. By Application

            15.14.2.4. By End User

    15.15. Australia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Product Type

            15.15.2.2. By Modality Type

            15.15.2.3. By Application

            15.15.2.4. By End User

    15.16. New Zealand

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Product Type

            15.16.2.2. By Modality Type

            15.16.2.3. By Application

            15.16.2.4. By End User

    15.17. GCC Countries

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Product Type

            15.17.2.2. By Modality Type

            15.17.2.3. By Application

            15.17.2.4. By End User

    15.18. South Africa

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Product Type

            15.18.2.2. By Modality Type

            15.18.2.3. By Application

            15.18.2.4. By End User

    15.19. Israel

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Product Type

            15.19.2.2. By Modality Type

            15.19.2.3. By Application

            15.19.2.4. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product Type

        16.3.3. By Modality Type

        16.3.4. By Application

        16.3.5. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. iRadimed Corporation

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Fresenius Kabi AG

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. B. Braun Melsungen AG

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Becton, Dickinson Company

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Smiths Medical

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Baxter International Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Arcomed AG

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Deltex Medical Group Plc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Philips Medical Systems

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. GE Healthcare

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

        17.1.11. Draeger Medical, Inc.

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

        17.1.12. Schwarzer Cardiotek GmbH

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

        17.1.13. Tensys Medical, Inc.

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology
Recommendations

Healthcare

MRI-Compatible IV Infusion Pump Systems Market

July 2017

REP-GB-3525

September 2022

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

MRI Compatible Patient Monitoring Systems Market